Search

Researchers at Pt. Ravishankar Shukla University in Raipur, India have published a review paper on the development of colorimetric and fluorometric paper-based analytical devices (PADs) for rapid point-of-care diagnosis of disease biomarkers. The paper discusses the principles of colorimetry and fluorometry and their application in detecting various biomolecules. Metal nanoparticles and quantum dots are highlighted as versatile sensing probes in these devices. The review provides an overview of the fabrication techniques, integration with portable devices, and diverse applications of these paper-based diagnostic platforms. The researchers conclude that the combination of metal nanoparticles and quantum dots with paper-based devices shows promise for advancing point-of-care diagnostics. [Extracted from the article]

A new report from South China Agricultural University discusses the challenges of detecting foodborne pathogens and the potential use of the CRISPR/Cas system integrated with paper-based analytical devices for rapid detection. The researchers highlight the advantages, current challenges, and future prospects of this approach. The study concludes that combining the efficient recognition ability of the CRISPR/Cas system with the simplicity of paper-based analytical devices could enable the rapid and sensitive detection of foodborne pathogens. This research has been peer-reviewed and provides valuable insights into improving food safety. [Extracted from the article]

A patent application has been submitted for a new technology called microfluidic enzyme-linked paper analytical device (mEL-PAD), which aims to improve the performance of lateral flow assays (LFAs) used for point-of-care testing. LFAs are commonly used for rapid diagnostic tests but have limitations in sensitivity and quantification. The mEL-PAD utilizes a vertical flow microfluidic device that incorporates enzyme-linked assays into paper-based devices. This technology has the potential to enhance the analytical performance of LFAs and enable easy-to-use point-of-care tests with high sensitivity and accuracy. The device can be used to detect various analytes, and a smartphone can be used to quantify the color change. [Extracted from the article]

A new paper published in Trends in Pharmacological Sciences by researchers at Insilico Medicine and ETH Zurich highlights the potential of TNIK as a therapeutic target for various aging-related diseases, including fibrosis, cancer, obesity, and Alzheimer's. The lead drug in Insilico's pipeline, INS018_055, is an AI-designed TNIK inhibitor currently in Phase II trials for idiopathic pulmonary fibrosis. TNIK has been found to play a significant role in cell migration, cytoskeletal organization, and cell proliferation in both healthy and malignant cells. The paper also explores TNIK's potential as a metabolic controller for combating obesity and Type 2 diabetes, as well as its emerging role in neurodegeneration. The researchers attribute TNIK's involvement in multiple diseases to its association with major hallmarks of aging. [Extracted from the article]

A review article published in Science China Life Sciences provides an overview of suppressor tRNA and its potential in gene therapy for genetic diseases caused by nonsense mutations. Suppressor tRNA is a molecule that can bypass stop codons in the genetic code, allowing translation to continue and resulting in the production of full-length proteins. The article discusses the advantages and disadvantages of suppressor tRNA therapy compared to other readthrough therapies and highlights the potential application of suppressor tRNA in treating genetic diseases. While suppressor tRNA therapy shows promise, it still faces challenges such as efficiency and potential cytotoxicity. The development of molecular biology, bioinformatics, synthetic biology, and delivery systems is driving the advancement of suppressor tRNA gene therapy. [Extracted from the article]

A recent report discusses research on biosensors conducted at Brigham Young University. The study focuses on the development of a low-cost, portable glutamine diagnostic test that can track a patient's response to treatment. The researchers engineered a cell-free glutamine biosensor to overcome limitations in previous studies, resulting in a shelf-stable, paper-based test with improved signal resolution. This advancement has the potential to improve the management of cancer and other health conditions, as well as expand the field of cell-free biosensing for the detection of various target molecules. [Extracted from the article]

The Neuropathy Action Foundation (NAF) has released a white paper titled "The Promise of Gene Therapy for Neuropathy and Rare Diseases," which explores the potential of gene therapy for neuropathy patients. The paper emphasizes the need for innovative policies to ensure equitable patient access to these treatments. Gene therapy has the potential to provide new options for the treatment of neuropathy, including inherited peripheral neuropathy caused by genetic mutations. The NAF is dedicated to ensuring that neuropathy patients have access to the necessary treatments to improve their quality of life. [Extracted from the article]

A recent research study conducted at Urmia University of Technology explored the effect of environmental temperature on gene transcription. The study utilized the Nose-Hoover thermostat to model the impact of temperature on gene expression, focusing on the degradation rates of messenger RNA and proteins. The researchers found that the optimal temperature for the production of mRNA molecules by Escherichia coli bacteria is 306 Kelvin. Additionally, the study revealed that faster degradation of mRNA molecules leads to increased transcription and a more chaotic system. This research provides valuable insights into the complex phenomenon of gene expression. [Extracted from the article]

A preprint abstract from biorxiv.org discusses the challenges of implementing enzyme-free nucleic acid amplification tests (NAATs) at the point of care (PoC) for communicable diseases. These tests are often resource-intensive and difficult to obtain in low-resource communities. The abstract presents a proof-of-concept NAAT that combines hybridization chain reaction (HCR) with paper-based nucleic acid filtration and enrichment to detect synthetic DNA at sub pM levels. The researchers demonstrate that by recreating the conditions of an in cellulo reaction in vitro, HCR can be enhanced to meet the needs of PoC NAATs. However, it is important to note that this preprint has not yet undergone peer review. [Extracted from the article]

Therefore, we explain PK concepts of biodistribution of AAV-based therapies and place key terminologies related to drug exposure and PD in the proper context. Keywords for this news article include: Philadelphia, Pennsylvania, United States, North and Central America, Bioengineering, Biopharmaceutical Companies, Biotechnology, Business, Drugs and Therapies, Gene Therapy, Genetics, Healthcare Biotechnology Companies, Technology, Therapy, Spark Therapeutics Inc. Keywords: Philadelphia; State:Pennsylvania; United States; North and Central America; Bioengineering; Biopharmaceutical Companies; Biotechnology; Business; Drugs and Therapies; Gene Therapy; Genetics; Healthcare Biotechnology Companies; Technology; Therapy EN Philadelphia State:Pennsylvania United States North and Central America Bioengineering Biopharmaceutical Companies Biotechnology Business Drugs and Therapies Gene Therapy Genetics Healthcare Biotechnology Companies Technology Therapy 919 919 1 09/04/23 20230908 NES 230908 2023 SEP 8 (NewsRx) -- By a News Reporter-Staff News Editor at Gene Therapy Weekly -- Research findings on Biotechnology - Gene Therapy are discussed in a new report. [Extracted from the article]

Researchers at the State University of New York (SUNY) Albany have developed a new method for detecting and identifying Salmonella, a common food-borne pathogen. The method uses a synthetic biology cascade reaction on a paper substrate, combining CRISPR-Cas12a and recombinase polymerase amplification (RPA) techniques. The sensor is capable of visually detecting as few as 100 copies of the Salmonella genome on a paper substrate, and has been successfully applied to detect Salmonella in contaminated milk and lettuce samples. The researchers believe that this versatile and practical method could be used to detect genomes from different organisms by simply changing a single RNA element. [Extracted from the article]

Rather than actively pump fluid through open channels, paper-fluidic devices leverage the inherent wicking ability of porous materials to transport fluid through multiple reagent zones. The sophisticated fluid transport including mixing, separating, and timed delivery of liquids performed in lab-on-chip devices can be achieved by incorporating three fundamental elements: pumps, routers, and valves. By eliminating the external pumping mechanism that microfluidic devices typically require, paper-fluidic devices are a much more portable alternative. [Extracted from the article]

The journal Letters in Applied Microbiology is organizing a themed collection on 'Emerging Horizons in Pseudomonas Biotechnology - Innovations from Early-Career Researchers'. This collection aims to showcase the innovative research conducted by early-career scientists in Pseudomonas biotechnology, focusing on the biotechnological applications of different Pseudomonas species in various research, industrial, and environmental contexts. The collection is a follow-up to the 3rd Pseudomonas Grassroots Meeting, which took place in Munich in November 2023 and was sponsored by Letters in Applied Microbiology. The organizers of the meeting hope to foster collaboration and inspire future innovations in Pseudomonas biotechnology. [Extracted from the article]

Keywords: Diagnostics and Screening; Enzymes and Coenzymes; Genetics; Polymerase; Testing EN Diagnostics and Screening Enzymes and Coenzymes Genetics Polymerase Testing 891 891 1 10/03/23 20231006 NES 231006 2023 OCT 8 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Investigators publish new report on diagnostics and screening. Diagnostics and Screening, Enzymes and Coenzymes, Genetics, Polymerase, Testing. [Extracted from the article]

By eliminating the external pumping mechanism that microfluidic devices typically require, paper-fluidic devices are a much more portable alternative. The method of claim 1, wherein the assay device is a paper-based nucleic acid amplification and detection assay device. Keywords: Diagnostics and Screening; Genetics; Health and Medicine; Immunoassay; Purdue Research Foundation EN Diagnostics and Screening Genetics Health and Medicine Immunoassay Purdue Research Foundation 8897 8897 1 05/08/23 20230512 NES 230512 2023 MAY 12 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Purdue Research Foundation (West Lafayette, Indiana, United States) has been issued patent number 11628434, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. [Extracted from the article]

The pump-free and paper-based sensor achieved quantitative analysis of influenza A virus (IAV) RNA and exosome microRNA within 1 h, with the lowest detect concentration of 104 TCID50/mL and 106 EV/mL for IAV and exosome, respectively." Keywords: Ames; State:Iowa; United States; North and Central America; Genetics; Influenza A Virus; RNA Viruses; Risk and Prevention; Viral; Viral RNA; Virology EN Ames State:Iowa United States North and Central America Genetics Influenza A Virus RNA Viruses Risk and Prevention Viral Viral RNA Virology 932 932 1 04/17/23 20230421 NES 230421 2023 APR 21 (NewsRx) -- By a News Reporter-Staff News Editor at Genomics & Genetics Weekly -- New research on RNA Viruses - Influenza A Virus is the subject of a report. [Extracted from the article]

Biosensors, Biotechnology, Genetics, Nanotechnology, Viral RNA Keywords for this news article include: University of California Riverside, Biotechnology, Genetics, Viral RNA, Biosensors, Nanotechnology. Keywords: Biosensors; Biotechnology; Genetics; Nanotechnology; Viral RNA EN Biosensors Biotechnology Genetics Nanotechnology Viral RNA 2509 2509 1 09/11/23 20230915 NES 230915 2023 SEP 15 (NewsRx) -- By a News Reporter-Staff News Editor at Genomics & Genetics Weekly -- Research findings on biosensors are discussed in a new report. [Extracted from the article]

A study conducted by researchers at Nanjing University of Chinese Medicine in China explored the role of the microbiota-gut-brain axis in the protective effect of pair-housing on post-stroke depression (PSD). The study used a mouse model of PSD induced by occluding the middle cerebral artery (MCAO) and restraint stress. The results showed that pair-housed mice had better performance on anxiety- and depression-like behaviors compared to PSD mice, and their intestinal flora was improved. Pair-housing also improved gut barrier disorder and inflammation caused by PSD. However, these improvements were reversed when the mice were given antibiotic water. The researchers concluded that pair-housing significantly improves PSD through the microbiota-gut-brain axis, and the homeostasis of gut microbiota is necessary for this protective effect. [Extracted from the article]

Keywords: Fuzhou; People's Republic of China; Asia; Cloud Computing; Deep Learning; Diagnostics and Screening; Genetics; Information Technology; Machine Learning; Testing EN Fuzhou People's Republic of China Asia Cloud Computing Deep Learning Diagnostics and Screening Genetics Information Technology Machine Learning Testing 1039 1039 1 05/02/23 20230505 NES 230505 2023 MAY 7 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- New research on Information Technology - Cloud Computing is the subject of a report. Keywords for this news article include: Fuzhou, People's Republic of China, Asia, Cloud Computing, Deep Learning, Diagnostics and Screening, Genetics, Information Technology, Machine Learning, Testing, Fuzhou University. [Extracted from the article]

A recent report from researchers at Birmingham Women's and Children's NHS Foundation Trust discusses the diagnosis and treatment of progressive familial intrahepatic cholestasis (PFIC), a rare liver disorder that primarily affects children. The researchers aimed to provide recommendations for the management of PFIC in clinical practice. They developed an algorithm for the diagnosis and treatment of children with suspected PFIC, which includes the use of licensed inhibitors of ileal bile acid transporters as the first-line treatment. The authors hope that these recommendations will help standardize the management of PFIC and raise awareness of current developments in the field. [Extracted from the article]

The method of claim 18, wherein the conjugating is of a protein, peptide, or polysaccharide and the protein, peptide, or polysaccharide is an antibody. For example, the protein, peptide, or polysaccharide can be an antibody, such as an antibody for a cytokine or a chemokine. [Extracted from the article]

Biosensors, Biotechnology, Drugs and Therapies, Emerging Technologies, Genetics, Nanoprobes, Nanotechnology, miRNA-Based Therapy, SERS Biosensors Keywords: Biosensors; Biotechnology; Drugs and Therapies; Emerging Technologies; Genetics; Nanoprobes; Nanotechnology; SERS Biosensors; miRNA-Based Therapy EN Biosensors Biotechnology Drugs and Therapies Emerging Technologies Genetics Nanoprobes Nanotechnology SERS Biosensors miRNA-Based Therapy 707 707 1 03/23/23 20230324 NES 230324 2023 MAR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Data detailed on miRNA-based therapy have been presented. [Extracted from the article]

Keywords: Sylhet; Bangladesh; Asia; Aspergillus; Cellulases; Enzymes and Coenzymes; Genetics; Glucanase; Glucosidases; Glycoside Hydrolases; Health and Medicine; Hydrolases EN Sylhet Bangladesh Asia Aspergillus Cellulases Enzymes and Coenzymes Genetics Glucanase Glucosidases Glycoside Hydrolases Health and Medicine Hydrolases 2023 FEB 24 (NewsRx) -- By a News Reporter-Staff News Editor at Genomics & Genetics Weekly -- Investigators discuss new findings in Aspergillus. According to the news editors, the research concluded: "Results herein provide a valuable resource for understanding cellulase genes in Aspergillus species and potential application of cellulase in textile and fermentable sugars production industries.". [Extracted from the article]

A report from the Royal Hospital for Children and Young People in Edinburgh, United Kingdom, discusses the potential benefits of stratified and precision nutrition in the management and prevention of inflammatory bowel disease (IBD). The report highlights the need for tailored dietary interventions based on an individual's characteristics, biology, gut microbiome, and environmental exposures. The research identifies four key themes: nutritional epidemiology for predicting IBD development, food-based dietary interventions, exclusive enteral nutrition for Crohn's disease management, and the use of pre- and probiotics for IBD management. However, the report concludes that there is currently insufficient evidence to make definitive recommendations for precision or stratified dietary therapy for patients with established IBD, and further research is needed to replicate early findings. [Extracted from the article]

Keywords for this news article include: Biotechnology, Genetics, Caring Cross, Gene Therapy, Bioengineering, Drugs and Therapies. Keywords: Bioengineering; Biotechnology; Caring Cross; Drugs and Therapies; Gene Therapy; Genetics EN Bioengineering Biotechnology Caring Cross Drugs and Therapies Gene Therapy Genetics 436 436 1 08/28/23 20230829 NES 230829 2023 SEP 1 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- Caring Cross, a 501(c)(3) non-profit dedicated to accelerating the development of advanced medicines and enabling access to cures for all patients, everywhere, announced its role in a newly published white paper from the Innovative Genomics Institute, titled "Making Genetic Therapies Affordable and Accessible.". [Extracted from the article]

Hsinchu, Taiwan, Asia, Genomics and Genetics, Retinal Neurons, Retinal Ganglion Cells, Risk and Prevention Keywords: Hsinchu; Taiwan; Asia; Genomics and Genetics; Retinal Ganglion Cells; Retinal Neurons; Risk and Prevention EN Hsinchu Taiwan Asia Genomics and Genetics Retinal Ganglion Cells Retinal Neurons Risk and Prevention 1066 1066 1 09/11/23 20230915 NES 230915 2023 SEP 15 (NewsRx) -- By a News Reporter-Staff News Editor at Genomics & Genetics Weekly -- Investigators discuss new findings in Genomics and Genetics. [Extracted from the article]

A recent preprint abstract highlights the issue of misidentified reagents in cancer research papers. The study found that a significant number of papers studying miR-145 had misidentified nucleotide sequence reagents and human cell lines. Additionally, the researchers discovered non-verifiable cell line identifiers that were not indexed in accessible repositories. This raises concerns about the reproducibility of research and calls for further investigation into the identities of these cell lines. However, it is important to note that this preprint has not yet undergone peer review. [Extracted from the article]

New research conducted by Universite Cheikh Anta Diop focuses on the issue of stunting in children under the age of 5. Stunting is associated with physical and cognitive deficits, socioeconomic disadvantage, and reduced life expectancy. The study aims to understand the causes of stunting and its effects in order to develop strategies to prevent and mitigate its consequences. The research involves epigenetic studies in India, Indonesia, and Senegal, examining the DNA methylation of babies, mothers, and fathers to identify predictive markers and therapeutic targets. The study has been approved by relevant Ethics Committees and the research data will be published and made available in public repositories. [Extracted from the article]

New research from the Beijing Institute of Pharmacology and Toxicology in China has identified a potential anti-Zika virus compound called XSJ2-46. The compound demonstrated potent in vitro activity against the Zika virus without requiring chemical phosphorylation and showed favorable pharmacokinetic and acute toxicity profiles. XSJ2-46 acted at the replication stage of the viral infection cycle and inhibited RNA-dependent RNA polymerases. In animal models, XSJ2-46 enhanced survival protection and decreased serum levels of Zika virus RNA. This research highlights the potential of utilizing the 5'-amino NI structure skeleton for developing antiviral compounds. [Extracted from the article]

A new study from the University of Texas Health San Antonio has explored bronchopulmonary dysplasia (BPD), a common complication of extreme prematurity. The researchers used an unsupervised machine learning approach to identify BPD subclasses, or endotypes, based on gene expression data. They found that T helper 17 cell differentiation was the most significant pathway differentiating the BPD endotypes. The study suggests that bioinformatic analyses can help identify BPD endotypes that are associated with clinical definitions of the disease. [Extracted from the article]

Keywords: Haryana; India; Asia; Genomics and Genetics; Drugs and Therapies; Semicarbazides; Semicarbazones; Sulfur Compounds; Thiosemicarbazones EN Haryana India Asia Genomics and Genetics Drugs and Therapies Semicarbazides Semicarbazones Sulfur Compounds Thiosemicarbazones 2278 2278 1 08/14/23 20230818 NES 230818 2023 AUG 18 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Investigators publish new report on Genomics and Genetics. Keywords for this news article include: Haryana, India, Asia, Genomics and Genetics, Drugs and Therapies, Semicarbazides, Semicarbazones, Sulfur Compounds, Thiosemicarbazones, Guru Jambheshwar University. Haryana, India, Asia, Genomics and Genetics, Drugs and Therapies, Semicarbazides, Semicarbazones, Sulfur Compounds, Thiosemicarbazones. [Extracted from the article]

Keywords: Tokyo; Japan; Asia; Cancer; Drugs and Therapies; Genetics; Health and Medicine; Lung Cancer; Lung Diseases and Conditions; Lung Neoplasms; Non-Small Cell Lung Cancer; Oncology EN Tokyo Japan Asia Cancer Drugs and Therapies Genetics Health and Medicine Lung Cancer Lung Diseases and Conditions Lung Neoplasms Non-Small Cell Lung Cancer Oncology 960 960 1 06/19/23 20230620 NES 230620 2023 JUN 20 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Oncology Week -- Data detailed on Oncology - Non-Small Cell Lung Cancer have been presented. For more information on this research see: Paper Serum-derived Exosomal Mir-125a-3p Predicts the Response To Anti-programmed Cell Death-1/programmed Cell Death-ligand 1 Monotherapy In Patients With Non-small Cell Lung Cancer. [Extracted from the article]

Vancouver, Canada, North and Central America, Enterobacteriaceae, Enzymes and Coenzymes, Foodborne Diseases and Conditions, Gammaproteobacteria, Genetics, Gram-Negative Bacteria, Gram-Negative Facultatively Anaerobic Rods, Polymerase, Proteobacteria, Recombinases, Salmonella, Salmonella enterica Keywords: Vancouver; Canada; North and Central America; Enterobacteriaceae; Enzymes and Coenzymes; Foodborne Diseases and Conditions; Gammaproteobacteria; Genetics; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Polymerase; Proteobacteria; Recombinases; Salmonella; Salmonella enterica EN Vancouver Canada North and Central America Enterobacteriaceae Enzymes and Coenzymes Foodborne Diseases and Conditions Gammaproteobacteria Genetics Gram-Negative Bacteria Gram-Negative Facultatively Anaerobic Rods Polymerase Proteobacteria Recombinases Salmonella Salmonella enterica 367 367 1 06/12/23 20230615 NES 230615 2023 JUN 15 (NewsRx) -- By a News Reporter-Staff News Editor at Food Weekly News -- New research on Gram-Negative Bacteria - Salmonella enterica is the subject of a report. [Extracted from the article]

This work builds on the concept of detecting cancer biomarkers, such as proteins or circulating tumor cells, in a patient's blood sample. Keywords: Biomarkers; Cancer; Diagnostics and Screening; Emerging Technologies; Engineering; Enzymes and Coenzymes; Genetics; Health and Medicine; Massachusetts Institute of Technology; Nanoparticles; Nanotechnology; Oncology; Protease; Technology; Tumors EN Biomarkers Cancer Diagnostics and Screening Emerging Technologies Engineering Enzymes and Coenzymes Genetics Health and Medicine Massachusetts Institute of Technology Nanoparticles Nanotechnology Oncology Protease Technology Tumors 18 18 1 05/08/23 20230508 NES 230508 2023 MAY 8 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Vaccine Week -- CAMBRIDGE, MA - MIT engineers have designed a new nanoparticle sensor that could enable early diagnosis of cancer with a simple urine test. [Extracted from the article]

A study conducted by researchers at the University of Sydney examined the presence of wrongly identified nucleotide sequences in high-impact-factor cancer research journals. The study found that 3.8% of nucleotide sequences in Molecular Cancer papers and 4.0% in Oncogene papers were wrongly identified. These wrongly identified sequences were distributed across a significant number of papers, including those from 2020. The study highlights the risks of relying on journal impact factors or citations as indicators of research quality. [Extracted from the article]

The article provides information on the ongoing debate within the medical field regarding the use of race as a factor in clinical decision-making. While some argue that race is a socially constructed concept and should not be used in medical models, economists in a new paper argue that race, despite its imprecise nature, can still provide useful information linked to factors like wealth, genetics, and the patient's physical environment.

Aneuploidy, Clinical Research, Clinical Trials and Studies, Genetics, Health and Medicine Keywords: Aneuploidy; Clinical Research; Clinical Trials and Studies; Genetics; Health and Medicine EN Aneuploidy Clinical Research Clinical Trials and Studies Genetics Health and Medicine 994 994 1 08/14/23 20230814 NES 230814 2023 AUG 14 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Investigators publish new report on aneuploidy. [Extracted from the article]

Keywords: Xi'an; People's Republic of China; Asia; Cardiovascular Research; Genetics; Health and Medicine; Kidney; Nephrology EN Xi'an People's Republic of China Asia Cardiovascular Research Genetics Health and Medicine Kidney Nephrology 172 172 1 05/02/23 20230501 NES 230501 2023 MAY 1 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- Research findings on Cardiovascular Research are discussed in a new report. According to the news editors, the research concluded: "Our findings demonstrate that transient high salt-induced epigenetic changes and persistent inflammatory activation play important roles in salt memory and its mediation of SS hypertension and renal damage.(." This research has been peer-reviewed. [Extracted from the article]

COVID-19 Model, Cardiovascular Diseases and Conditions, Disease Model, Drugs and Therapies, Embolism and Thrombosis, Epidemiology, Genetics, Health and Medicine, Hematology, Pharmaceuticals, Risk and Prevention, Thrombosis, Vascular Diseases and Conditions Keywords: COVID-19 Model; Cardiovascular Diseases and Conditions; Disease Model; Drugs and Therapies; Embolism and Thrombosis; Epidemiology; Genetics; Health and Medicine; Hematology; Pharmaceuticals; Risk and Prevention; Thrombosis; Vascular Diseases and Conditions EN COVID-19 Model Cardiovascular Diseases and Conditions Disease Model Drugs and Therapies Embolism and Thrombosis Epidemiology Genetics Health and Medicine Hematology Pharmaceuticals Risk and Prevention Thrombosis Vascular Diseases and Conditions 13 13 1 03/27/23 20230327 NES 230327 2023 MAR 27 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx COVID-19 Weekly -- Current study results on thrombosis have been published. [Extracted from the article]

Keywords: London; United Kingdom; Europe; Cardiology; Cardiovascular; Cardiovascular Research; Genomics and Genetics; Health and Medicine; Heart; Heart Research; Myocardium; Pediatrics EN London United Kingdom Europe Cardiology Cardiovascular Cardiovascular Research Genomics and Genetics Health and Medicine Heart Heart Research Myocardium Pediatrics 2023 MAR 4 (NewsRx) -- By a News Reporter-Staff News Editor at Pediatrics Week -- New research on Genomics and Genetics is the subject of a report. Our news correspondents report that additional information may be obtained by contacting Steffen E. Petersen, William Harvey Research Institute, National Institute for Health and Care Research Barts Biomedical Research Centre, Queen Mary-University of London, London, UK. [Extracted from the article]

Researchers from Banat University of Agricultural Sciences and Veterinary Medicine conducted a study on the Romanian Mioritic Shepherd Dog breed. The aim of the study was to estimate the variance in 12 body measurements of 23 female dogs from this breed. The research found that there was a large variance in certain measurements, such as height at the middle back and width of the croup, while other measurements had a moderate variance. These findings are important for developing a genetic improvement program for this breed. For more information, readers can refer to the article "Variance Estimation between Different Body Measurements at the Females Population from Romanian Mioritic Shepherd Dog Breed, to Develop a Genetic Improvement Program" published in Scientific Papers Animal Science and Biotechnologies. [Extracted from the article]

A new study on gynecological endocrinology has been conducted to explore the genes associated with premature ovarian insufficiency (POI) and identify key themes and future directions in this field. The study analyzed articles and reviews related to POI genes published between 1990 and 2022. The findings revealed that the United States and China were the top countries publishing papers on this topic, with Shandong University and Qin Y's team being the most prolific contributors. The study identified X-chromosome abnormalities, transcription factor mutations, and FMR1 genes as important areas of research in POI. The research aims to enhance understanding of the genetic dynamics of POI and contribute to the development of improved diagnosis and treatment options. [Extracted from the article]